IONS · Ionis Pharmaceuticals Inc
Market Cap
$9.65B
Shares
166.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-04 | 2026-09-03 | |
| 8-K | 2026-09-04 | — | |
| 10-Q | 2026-07-29 | 2026-06-30 | |
| 8-K | 2026-07-29 | — | |
| 8-K | 2026-07-10 | 2026-07-09 | |
| 8-K | 2026-07-09 | — | |
| 8-K | 2026-06-24 | — | |
| 8-K | 2026-06-12 | — | |
| Investor Event Transcript | 2026-06-10 | 2026-06-30 | |
| 8-K | 2026-06-08 | 2026-06-04 | |
| 8-K | 2026-05-28 | — | |
| 8-K | 2026-04-29 | — | |
| 10-Q | 2026-04-29 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-04 | |
| 8-K | 2026-04-21 | — | |
| 8-K | 2026-03-09 | 2026-03-03 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-17 | 2025-11-11 | |
| 8-K | 2025-11-10 | 2025-11-08 | |
| 8-K/A | 2025-11-03 | 2025-10-28 | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-09-22 | — | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-21 | — | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-10 | 2025-06-05 | |
| 8-K | 2025-05-19 | — | |
| 10-Q | 2025-04-30 | 2025-03-31 | |
| 8-K | 2025-04-30 | — | |
| DEF 14A | 2025-04-25 | 2025-06-05 | |
| 8-K | 2025-03-12 | 2025-03-11 | |
| 8-K | 2025-02-19 | — | |
| 10-K | 2025-02-19 | 2024-12-31 | |
| 8-K | 2024-12-20 | 2024-12-19 | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-09-12 | 2024-09-09 | |
| 8-K | 2024-09-09 | — | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-06-18 | — | |
| 8-K | 2024-06-10 | 2024-06-06 | |
| 8-K | 2024-05-31 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 |
Showing 1–50 of 138 filings
Key facts
CIK
874015
CUSIP
462222100
13F (30d)
368 filings
356 filers
Visit website
Investor relations